HC Wainwright Reiterates “Buy” Rating for XOMA (NASDAQ:XOMA)
XOMA (NASDAQ:XOMA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $104.00 target price on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 307.84% from the stock’s current price. […]
XOMA (NASDAQ:XOMA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $104.00 target price on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 307.84% from the stock’s current price. […]
